Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), a biopharmaceutical company with a market capitalization of $2.68 billion ...
Vigil posted positive phase 1 results for VG-3927, but competitor Alector's failure raises concerns about phase 2. Click here ...
In a legal dispute that is nearly identical to a case playing out in LoDo, a local landlord is accusing 7-Eleven of allowing one of its most prominent Boulder stores to become a homeless hangout, drug ...
After the Red No. 3 ban, there are now eight color additives approved by the FDA. They are FD&C Blue No. 1, FD&C Blue No. 2, FD&C Green No. 3, Orange B, Citrus Red No. 2, FD&C Red No. 40, FD&C Yellow ...
Under the agreement, Neomorph will receive an undisclosed upfront payment from AbbVie and be eligible for up to $1.64 billion in aggregate option fees and milestones.
Inflation was a top issue that helped propel Donald Trump back into the White House. But actions the new president has taken in his first days on the job could hit Americans - particularly seniors - ...
After years of false starts, members of the Pennsylvania legislature are restarting a debate over legalizing recreational ...
It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in ...
Libertarian and crypto allies of Ross Ulbricht, who was serving a life sentence for distributing drugs on his Silk Road ...
Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...
During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...